WebMD Health Corp. Announces Intention To Commence Tender Offer To Repurchase Up To 5,700,000 Shares of its Common Stock

WebMD Health Corp. Announces Intention To Commence Tender Offer To Repurchase
Up To 5,700,000 Shares of its Common Stock

NEW YORK, Nov. 3 /PRNewswire-FirstCall/ -- WebMD Health Corp. (Nasdaq: WBMD)
announced today that it intends to commence a tender offer next week to
purchase up to 5,700,000 shares of its common stock at a price per share of
$36.00. The last reported sales price per share of WebMD's common stock on
the Nasdaq Global Select Market on November 3, 2009 was $34.26 per share. The
number of shares proposed to be purchased in the tender offer represents
approximately 10% of WebMD's currently outstanding common shares.

Following the merger of HLTH Corporation into WebMD, completed on October 23,
2009, WebMD has approximately $1 billion in cash and investments. WebMD will
use a portion of its cash and investments to fund the tender offer. The Board
of Directors of WebMD, after evaluating expected capital requirements of
WebMD's operations and other expected cash commitments, as well as the
additional shares of WebMD common stock potentially issuable upon conversion
of WebMD's 1.75% Convertible Notes, believes that purchasing shares of WebMD's
common stock in the tender offer represents a superior alternative to other
available uses of the funds required for the tender offer.

None of WebMD, its Board of Directors, or the information agent for the tender
offer will make any recommendations to stockholders as to whether to tender or
refrain from tendering their shares into the tender offer. Stockholders must
decide how many shares they will tender, if any.

THIS PRESS RELEASE IS FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSTITUTE
AN OFFER TO BUY OR THE SOLICITATION OF AN OFFER TO SELL SHARES OF WEBMD HEALTH
CORP. COMMON STOCK. THE TENDER OFFER WILL BE MADE ONLY PURSUANT TO AN OFFER
TO PURCHASE, LETTER OF TRANSMITTAL AND RELATED MATERIALS THAT WEBMD INTENDS TO
DISTRIBUTE TO ITS STOCKHOLDERS AND FILE WITH THE SECURITIES AND EXCHANGE
COMMISSION. STOCKHOLDERS AND INVESTORS SHOULD READ CAREFULLY THE OFFER TO
PURCHASE, LETTER OF TRANSMITTAL AND RELATED MATERIALS BECAUSE THEY WILL
CONTAIN IMPORTANT INFORMATION, INCLUDING THE VARIOUS TERMS OF, AND CONDITIONS
TO, THE TENDER OFFER. STOCKHOLDERS AND INVESTORS WILL BE ABLE TO OBTAIN A FREE
COPY OF THE TENDER OFFER STATEMENT ON SCHEDULE TO, THE OFFER TO PURCHASE,
LETTER OF TRANSMITTAL AND OTHER DOCUMENTS THAT WEBMD INTENDS TO FILE WITH THE
SECURITIES AND EXCHANGE COMMISSION AT THE COMMISSION'S WEBSITE AT WWW.SEC.GOV
OR BY CALLING THE INFORMATION AGENT (TO BE IDENTIFIED AT THE TIME THE OFFER IS
MADE) FOR THE TENDER OFFER. STOCKHOLDERS ARE URGED TO CAREFULLY READ THESE
MATERIALS PRIOR TO MAKING ANY DECISION WITH RESPECT TO THE TENDER OFFER.

About WebMD

WebMD Health Corp. (Nasdaq: WBMD) is the leading provider of health
information services, serving consumers, physicians, healthcare professionals,
employers and health plans through our public and private online portals and
health-focused publications.

The WebMD Health Network includes WebMD Health, Medscape, MedicineNet,
eMedicine, eMedicine Health, RxList and theHeart.org.

All statements contained in this press release, other than statements of
historical fact, are forward-looking statements, including those regarding:
the expected timing of the tender offer described in this press release. These
statements are based on our current plans and expectations and involve risks
and uncertainties that could cause actual future events or results to be
different than those described in or implied by such forward-looking
statements, including risks and uncertainties regarding: changes in financial
markets; changes in economic, political or regulatory conditions or other
trends affecting the healthcare, Internet and information technology
industries; and changes in facts and circumstances and other uncertainties
concerning the completion of the tender offer. Further information about
these matters can be found in our Securities and Exchange Commission filings.
Except as required by applicable law or regulation, we do not undertake any
obligation to update our forward-looking statements to reflect future events
or circumstances.

WebMD®, Medscape®, eMedicine®, MedicineNet®, RxList®, Subimo®, Medsite®, and
Summex®, are trademarks of WebMD Health Corp. or its subsidiaries.

SOURCE WebMD

Investors: Risa Fisher, +1-212-624-3817, rfisher@webmd.net; or Media: Kate
Hahn, +1-212-624-3760, khahn@webmd.net